Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

French face dilemma over adopting biotech patenting Directive

This article was originally published in Clinica

Executive Summary

France should drop its opposition to the patenting of genes and take steps to adopt the EU biotechnology patenting Directive in its entirety. This is the controversial message contained in a report submitted to the French Industry Ministry on March 11. The report was commissioned by Finance Minister Laurent Fabius and drafted by a working group headed by Noelle Lenoir, a judge at the French Constitutional Council and president of the European Group on Ethics in Science and New Technologies

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065881

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel